These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
508 related items for PubMed ID: 25877817
1. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets. Kato M, Natarajan R. Ann N Y Acad Sci; 2015 Sep; 1353(1):72-88. PubMed ID: 25877817 [Abstract] [Full Text] [Related]
2. Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy. Mafi A, Yadegar N, Salami M, Salami R, Vakili O, Aghadavod E. Pathol Res Pract; 2021 Nov; 227():153618. PubMed ID: 34649056 [Abstract] [Full Text] [Related]
6. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression. Mafi A, Aghadavod E, Mirhosseini N, Mobini M, Asemi Z. J Cell Physiol; 2018 Jan; 234(1):42-50. PubMed ID: 30078212 [Abstract] [Full Text] [Related]
7. MicroRNA: A new generation therapeutic target in diabetic nephropathy. Dewanjee S, Bhattacharjee N. Biochem Pharmacol; 2018 Sep; 155():32-47. PubMed ID: 29940170 [Abstract] [Full Text] [Related]
8. MicroRNAs in diabetic nephropathy: From molecular mechanisms to new therapeutic targets of treatment. Yarahmadi A, Shahrokhi SZ, Mostafavi-Pour Z, Azarpira N. Biochem Pharmacol; 2021 Jul; 189():114301. PubMed ID: 33203517 [Abstract] [Full Text] [Related]
9. Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq. Rubin A, Salzberg AC, Imamura Y, Grivitishvilli A, Tombran-Tink J. BMC Genomics; 2016 Nov 17; 17(1):936. PubMed ID: 27855634 [Abstract] [Full Text] [Related]
12. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression. Wang Y, Liu L, Peng W, Liu H, Liang L, Zhang X, Mao Y, Zhou X, Shi M, Xiao Y, Zhang F, Zhang Y, Liu L, Yan R, Guo B. J Cell Physiol; 2019 Aug 17; 234(10):17925-17936. PubMed ID: 30847937 [Abstract] [Full Text] [Related]
13. Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy. DiStefano JK, Taila M, Alvarez ML. Curr Diab Rep; 2013 Aug 17; 13(4):582-91. PubMed ID: 23666892 [Abstract] [Full Text] [Related]
14. Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy. Lv J, Wu Y, Mai Y, Bu S. J Diabetes Res; 2020 Aug 17; 2020():3960857. PubMed ID: 32656264 [Abstract] [Full Text] [Related]
16. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy via Novel Biomarkers and Competing Endogenous RNA Network. Guo M, Dai Y, Jiang L, Gao J. Front Endocrinol (Lausanne); 2022 Aug 17; 13():934022. PubMed ID: 35909518 [Abstract] [Full Text] [Related]
18. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy. Yang Y, Xiao L, Li J, Kanwar YS, Liu F, Sun L. Med Hypotheses; 2013 Aug 17; 81(2):274-8. PubMed ID: 23683774 [Abstract] [Full Text] [Related]